Will a doctor prescribe rapamycin?

Rapamycin (also known as sirolimus) has been an approved medication for many years and is actively prescribed in clinical practice following kidney transplantation. In some countries, monitoring blood levels is even required by law, which illustrates how seriously this drug is embedded in regulated medicine¹.

Outside kidney transplantation, doctors also prescribe related compounds that work in the same way as rapamycin. Everolimus, a closely related drug that blocks the same biological pathway, is used in patients with Tuberous Sclerosis Complex (TSC), a rare genetic condition that can cause, among other things, severe epilepsy. In a German multicentre study of 268 TSC patients, 32.5% received everolimus². After liver transplantation, sirolimus and everolimus are also used as alternatives to another class of immunosuppressive agents, as shown by a meta-analysis of multiple randomised trials³.

A very different question is whether a doctor will prescribe rapamycin to healthy people who want to slow ageing. This falls outside approved indications and is not yet standard practice. Animal research shows promising signals, but translation to humans is proving difficult: clinical studies frequently fail to produce the hoped-for results and regularly fall short of expectations⁴. There is therefore insufficient basis for a doctor to prescribe rapamycin as an anti-ageing drug.

In summary, the answer depends entirely on the patient's situation. For approved indications such as kidney transplantation or TSC, prescribing is very common. Outside those indications, and certainly for healthy people who want to slow their ageing, a conventional doctor will not prescribe it at this time.